232 related articles for article (PubMed ID: 35079804)
1. Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome.
Acosta-Ampudia Y; Monsalve DM; Rojas M; Rodríguez Y; Zapata E; Ramírez-Santana C; Anaya JM
J Infect Dis; 2022 Jun; 225(12):2155-2162. PubMed ID: 35079804
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory Cytokine Profiles in Both Mild Symptomatic and Asymptomatic SARS-CoV-2-Infected Egyptian Individuals and a Proposed Relationship to Post-COVID-19 Sequela.
Bahgat MM; Nadeem R; Nasraa MH; Amer K; Hassan WA; ELGarhy FM; Reda S; Abd-Elshafy DN
Viral Immunol; 2023 Nov; 36(9):600-609. PubMed ID: 37831918
[TBL] [Abstract][Full Text] [Related]
3. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection as a trigger of autoimmune response.
Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
[TBL] [Abstract][Full Text] [Related]
5. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.
Petrone L; Petruccioli E; Vanini V; Cuzzi G; Najafi Fard S; Alonzi T; Castilletti C; Palmieri F; Gualano G; Vittozzi P; Nicastri E; Lepore L; Antinori A; Vergori A; Caccamo N; Cantini F; Girardi E; Ippolito G; Grifoni A; Goletti D
Clin Microbiol Infect; 2021 Feb; 27(2):286.e7-286.e13. PubMed ID: 33045370
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Severe Acute Respiratory Syndrome Coronavirus 2 Antigen-Specific Systemic Immune Responses in Multisystem Inflammatory Syndrome in Children and Reversal After Recovery.
Kumar NP; Venkataraman A; Nancy A; Moideen K; Varadarjan P; Selladurai E; Sangaralingam T; Selvam R; Thimmaiah A; Natarajan S; Ramasamy G; Hissar S; Radayam Ranganathan U; Babu S
J Infect Dis; 2022 Sep; 226(7):1215-1223. PubMed ID: 35932220
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity is a hallmark of post-COVID syndrome.
Rojas M; Rodríguez Y; Acosta-Ampudia Y; Monsalve DM; Zhu C; Li QZ; Ramírez-Santana C; Anaya JM
J Transl Med; 2022 Mar; 20(1):129. PubMed ID: 35296346
[TBL] [Abstract][Full Text] [Related]
8. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
9. Is post-COVID syndrome an autoimmune disease?
Anaya JM; Herrán M; Beltrán S; Rojas M
Expert Rev Clin Immunol; 2022 Jul; 18(7):653-666. PubMed ID: 35658801
[TBL] [Abstract][Full Text] [Related]
10. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
11. Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection.
Wiech M; Chroscicki P; Swatler J; Stepnik D; De Biasi S; Hampel M; Brewinska-Olchowik M; Maliszewska A; Sklinda K; Durlik M; Wierzba W; Cossarizza A; Piwocka K
Front Immunol; 2022; 13():886431. PubMed ID: 35757700
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 triggering autoimmune diseases.
Mobasheri L; Nasirpour MH; Masoumi E; Azarnaminy AF; Jafari M; Esmaeili SA
Cytokine; 2022 Jun; 154():155873. PubMed ID: 35461172
[TBL] [Abstract][Full Text] [Related]
13. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study.
Molodtsov IA; Kegeles E; Mitin AN; Mityaeva O; Musatova OE; Panova AE; Pashenkov MV; Peshkova IO; Alsalloum A; Asaad W; Budikhina AS; Deryabin AS; Dolzhikova IV; Filimonova IN; Gracheva AN; Ivanova OI; Kizilova A; Komogorova VV; Komova A; Kompantseva NI; Kucheryavykh E; Lagutkin DА; Lomakin YA; Maleeva AV; Maryukhnich EV; Mohammad A; Murugin VV; Murugina NE; Navoikova A; Nikonova MF; Ovchinnikova LA; Panarina Y; Pinegina NV; Potashnikova DM; Romanova EV; Saidova AA; Sakr N; Samoilova AG; Serdyuk Y; Shakirova NT; Sharova NI; Sheetikov SA; Shemetova AF; Shevkova LV; Shpektor AV; Trufanova A; Tvorogova AV; Ukrainskaya VM; Vinokurov AS; Vorobyeva DA; Zornikova KV; Efimov GA; Khaitov MR; Kofiadi IA; Komissarov AA; Logunov DY; Naigovzina NB; Rubtsov YP; Vasilyeva IA; Volchkov P; Vasilieva E
Clin Infect Dis; 2022 Aug; 75(1):e1-e9. PubMed ID: 35435222
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.
Shibabaw T
J Inflamm Res; 2020; 13():673-680. PubMed ID: 33116747
[TBL] [Abstract][Full Text] [Related]
15. CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome.
Guasp M; Muñoz-Sánchez G; Martínez-Hernández E; Santana D; Carbayo Á; Naranjo L; Bolós U; Framil M; Saiz A; Balasa M; Ruiz-García R; Sánchez-Valle R;
Front Immunol; 2022; 13():866153. PubMed ID: 35479062
[TBL] [Abstract][Full Text] [Related]
16. Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection.
Chaudhari S; Dey Pereira S; Asare-Warehene M; Naha R; Kabekkodu SP; Tsang BK; Satyamoorthy K
J Ovarian Res; 2021 Feb; 14(1):39. PubMed ID: 33632295
[TBL] [Abstract][Full Text] [Related]
17. Persistent IgG anticardiolipin autoantibodies are associated with post-COVID syndrome.
Bertin D; Kaphan E; Weber S; Babacci B; Arcani R; Faucher B; Ménard A; Brodovitch A; Mege JL; Bardin N
Int J Infect Dis; 2021 Dec; 113():23-25. PubMed ID: 34614444
[TBL] [Abstract][Full Text] [Related]
18. Detection of IFNγ-Secreting CD4
Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
[TBL] [Abstract][Full Text] [Related]
19. Immunological fingerprint in coronavirus disease-19 convalescents with and without post-COVID syndrome.
Augustin M; Heyn F; Ullrich S; Sandaradura de Silva U; Albert MC; Linne V; Schlotz M; Schommers P; Pracht E; Horn C; Suarez I; Simonis A; Picard LK; Zoufaly A; Wenisch C; Fätkenheuer G; Gruell H; Klein F; Hallek M; Walczak H; Rybniker J; Theobald SJ; Lehmann C
Front Med (Lausanne); 2023; 10():1129288. PubMed ID: 37168268
[TBL] [Abstract][Full Text] [Related]
20. The intersection of COVID-19 and autoimmunity.
Knight JS; Caricchio R; Casanova JL; Combes AJ; Diamond B; Fox SE; Hanauer DA; James JA; Kanthi Y; Ladd V; Mehta P; Ring AM; Sanz I; Selmi C; Tracy RP; Utz PJ; Wagner CA; Wang JY; McCune WJ
J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34710063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
